 Elizabeth Humes
Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 24 | 2026 | 3193 | 1.520 |
Why?
| | Transgender Persons | 6 | 2024 | 210 | 0.910 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 2023 | 237 | 0.490 |
Why?
| | Sexual and Gender Minorities | 3 | 2024 | 259 | 0.410 |
Why?
| | Viral Load | 3 | 2026 | 526 | 0.290 |
Why?
| | Gonorrhea | 2 | 2021 | 63 | 0.290 |
Why?
| | Anti-HIV Agents | 3 | 2026 | 912 | 0.240 |
Why?
| | Cohort Studies | 10 | 2026 | 6013 | 0.230 |
Why?
| | United States | 14 | 2026 | 16098 | 0.200 |
Why?
| | Health Care Costs | 1 | 2026 | 425 | 0.190 |
Why?
| | CD4 Lymphocyte Count | 4 | 2026 | 280 | 0.180 |
Why?
| | HIV Seropositivity | 1 | 2023 | 119 | 0.180 |
Why?
| | RNA, Viral | 1 | 2026 | 692 | 0.180 |
Why?
| | Dyslipidemias | 1 | 2024 | 184 | 0.180 |
Why?
| | Psychosurgery | 1 | 2021 | 9 | 0.170 |
Why?
| | Coinfection | 1 | 2022 | 143 | 0.160 |
Why?
| | Epidemics | 1 | 2022 | 96 | 0.160 |
Why?
| | Medicare | 1 | 2026 | 903 | 0.160 |
Why?
| | Homosexuality, Male | 4 | 2024 | 231 | 0.160 |
Why?
| | HIV-1 | 1 | 2026 | 908 | 0.150 |
Why?
| | Chlamydia Infections | 1 | 2021 | 79 | 0.150 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 92 | 0.150 |
Why?
| | Hepatitis C | 1 | 2022 | 256 | 0.150 |
Why?
| | Laser Therapy | 1 | 2021 | 144 | 0.150 |
Why?
| | Crime Victims | 1 | 2021 | 129 | 0.150 |
Why?
| | Life Expectancy | 1 | 2019 | 73 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2021 | 140 | 0.150 |
Why?
| | Quality Control | 1 | 2019 | 161 | 0.140 |
Why?
| | Syphilis | 1 | 2019 | 38 | 0.140 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 185 | 0.140 |
Why?
| | Sexually Transmitted Diseases | 1 | 2021 | 168 | 0.140 |
Why?
| | Adult | 16 | 2026 | 40777 | 0.140 |
Why?
| | Age Distribution | 3 | 2023 | 403 | 0.130 |
Why?
| | Male | 19 | 2026 | 72842 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 668 | 0.130 |
Why?
| | Humans | 28 | 2026 | 145474 | 0.130 |
Why?
| | Incidence | 5 | 2024 | 2923 | 0.120 |
Why?
| | Models, Theoretical | 1 | 2019 | 558 | 0.120 |
Why?
| | Risk Factors | 7 | 2024 | 10885 | 0.110 |
Why?
| | Food Microbiology | 1 | 2015 | 39 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2024 | 1097 | 0.110 |
Why?
| | Hypertension | 1 | 2024 | 1273 | 0.110 |
Why?
| | Female | 17 | 2026 | 78844 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1210 | 0.110 |
Why?
| | Foodborne Diseases | 1 | 2015 | 59 | 0.100 |
Why?
| | Meiosis | 1 | 2013 | 101 | 0.090 |
Why?
| | DNA Transposable Elements | 1 | 2013 | 124 | 0.090 |
Why?
| | Schizosaccharomyces | 1 | 2013 | 86 | 0.090 |
Why?
| | Prescriptions | 2 | 2022 | 74 | 0.090 |
Why?
| | Nucleosomes | 1 | 2013 | 163 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1196 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 1102 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2187 | 0.080 |
Why?
| | Baltimore | 2 | 2021 | 72 | 0.080 |
Why?
| | Middle Aged | 8 | 2026 | 36215 | 0.080 |
Why?
| | Neoplasms | 1 | 2024 | 2906 | 0.070 |
Why?
| | Aged | 6 | 2026 | 26153 | 0.070 |
Why?
| | Young Adult | 5 | 2024 | 14218 | 0.070 |
Why?
| | Public Health Surveillance | 2 | 2019 | 83 | 0.060 |
Why?
| | Live Birth | 1 | 2006 | 81 | 0.060 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2006 | 63 | 0.060 |
Why?
| | Sexual Behavior | 2 | 2021 | 494 | 0.060 |
Why?
| | Pregnancy Trimester, First | 1 | 2006 | 139 | 0.060 |
Why?
| | Prevalence | 2 | 2024 | 2865 | 0.060 |
Why?
| | Southeastern United States | 1 | 2024 | 37 | 0.050 |
Why?
| | Quinazolines | 1 | 2006 | 266 | 0.050 |
Why?
| | Adolescent | 5 | 2024 | 22529 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2019 | 2588 | 0.050 |
Why?
| | Population Density | 1 | 2023 | 89 | 0.050 |
Why?
| | Multimorbidity | 1 | 2024 | 64 | 0.050 |
Why?
| | Food Supply | 1 | 2024 | 85 | 0.050 |
Why?
| | Housing | 1 | 2024 | 142 | 0.050 |
Why?
| | Social Stigma | 1 | 2024 | 172 | 0.040 |
Why?
| | Aging | 2 | 2023 | 1969 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2022 | 100 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2021 | 72 | 0.040 |
Why?
| | Hepacivirus | 1 | 2022 | 242 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2026 | 8333 | 0.040 |
Why?
| | Social Support | 1 | 2024 | 646 | 0.040 |
Why?
| | HIV | 1 | 2021 | 251 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 526 | 0.040 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2021 | 279 | 0.040 |
Why?
| | Internet | 1 | 2024 | 689 | 0.040 |
Why?
| | Prospective Studies | 2 | 2022 | 8057 | 0.040 |
Why?
| | Anti-Retroviral Agents | 1 | 2022 | 251 | 0.040 |
Why?
| | Heterosexuality | 1 | 2019 | 46 | 0.040 |
Why?
| | Computer Simulation | 1 | 2023 | 1003 | 0.040 |
Why?
| | North America | 1 | 2019 | 302 | 0.040 |
Why?
| | Cause of Death | 1 | 2021 | 470 | 0.040 |
Why?
| | Comorbidity | 1 | 2024 | 1661 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2026 | 2953 | 0.030 |
Why?
| | Population Surveillance | 1 | 2021 | 484 | 0.030 |
Why?
| | Sexual Partners | 1 | 2019 | 193 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 769 | 0.030 |
Why?
| | Shiga Toxins | 1 | 2015 | 3 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 493 | 0.030 |
Why?
| | Connecticut | 1 | 2015 | 25 | 0.030 |
Why?
| | Escherichia coli O157 | 1 | 2015 | 14 | 0.030 |
Why?
| | Communicable Diseases, Emerging | 1 | 2015 | 39 | 0.030 |
Why?
| | Salmonella | 1 | 2015 | 47 | 0.030 |
Why?
| | Community Networks | 1 | 2015 | 57 | 0.030 |
Why?
| | Infant | 2 | 2022 | 10077 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2006 | 2382 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2013 | 67 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3413 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2013 | 130 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 506 | 0.020 |
Why?
| | Mass Screening | 1 | 2021 | 1360 | 0.020 |
Why?
| | Genome | 1 | 2013 | 305 | 0.020 |
Why?
| | DNA Repair | 1 | 2013 | 254 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 637 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1323 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 443 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2015 | 6447 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 6066 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 11772 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2006 | 89 | 0.010 |
Why?
| | Phenotype | 1 | 2013 | 3155 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2006 | 688 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 17291 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11853 | 0.010 |
Why?
| | Child | 1 | 2015 | 22707 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2214 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 7202 | 0.010 |
Why?
|
|
Humes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|